These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33445954)

  • 61. Life-threatening adverse events following therapeutic opioid administration in adults: is pharmacogenetic analysis useful?
    Madadi P; Sistonen J; Silverman G; Gladdy R; Ross CJ; Carleton BC; Carvalho JC; Hayden MR; Koren G
    Pain Res Manag; 2013; 18(3):133-6. PubMed ID: 23748253
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence.
    Blum K; Chen ALC; Thanos PK; Febo M; Demetrovics Z; Dushaj K; Kovoor A; Baron D; Smith DE; Roy AK; Fried L; Chen TJH; Chapman E; Modestino EJ; Steinberg B; Badgaiyan RD
    Front Biosci (Elite Ed); 2018 Jan; 10(1):175-196. PubMed ID: 28930612
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacogenetics of opioid response.
    Somogyi AA; Coller JK; Barratt DT
    Clin Pharmacol Ther; 2015 Feb; 97(2):125-7. PubMed ID: 25670515
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects.
    Rhodin A; Grönbladh A; Ginya H; Nilsson KW; Rosenblad A; Zhou Q; Enlund M; Hallberg M; Gordh T; Nyberg F
    Mol Brain; 2013 Feb; 6():8. PubMed ID: 23402298
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacogenomics in Pain Management.
    Saba R; Kaye AD; Urman RD
    Anesthesiol Clin; 2017 Jun; 35(2):295-304. PubMed ID: 28526150
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Genetic polymorphisms and opioid therapies].
    Landau R
    Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Genetics, pain and analgesia].
    Stamer U; Bayerer B; Stüber F
    Anaesthesist; 2006 Jul; 55(7):746-52. PubMed ID: 16625360
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The genetic influences on oxycodone response characteristics in human experimental pain.
    Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J
    Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Personalized therapy in pain management: where do we stand?
    Stamer UM; Zhang L; Stüber F
    Pharmacogenomics; 2010 Jun; 11(6):843-64. PubMed ID: 20504256
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Using pharmacogenetics to structure individual pain management protocols in total knee arthroplasty.
    Hamilton WG; Gargiulo JM; Parks NL
    Bone Joint J; 2020 Jun; 102-B(6_Supple_A):73-78. PubMed ID: 32475277
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancer pain.
    Mercadante S
    Curr Opin Support Palliat Care; 2013 Jun; 7(2):139-43. PubMed ID: 23572159
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genetics and genomics in postoperative pain and analgesia.
    Palada V; Kaunisto MA; Kalso E
    Curr Opin Anaesthesiol; 2018 Oct; 31(5):569-574. PubMed ID: 29994939
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacogenetics of Postoperative Pain Management: A Review.
    Aroke EN; Kittelsrud JM
    AANA J; 2020 Jun; 88(3):229-236. PubMed ID: 32442101
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Prescription of antidepressants in the treatment of pain: role of pharmacogenetics].
    Rodieux F; Piguet V; Berney P; Desmeules J; Besson M
    Rev Med Suisse; 2015 Jun; 11(480):1374-9. PubMed ID: 26267942
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
    Linares OA; Daly D; Linares AD; Stefanovski D; Boston RC
    Pain Med; 2014 May; 15(5):791-806. PubMed ID: 24517173
    [TBL] [Abstract][Full Text] [Related]  

  • 76. OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients.
    Viet CT; Dang D; Aouizerat BE; Miaskowski C; Ye Y; Viet DT; Ono K; Schmidt BL
    J Pain; 2017 Sep; 18(9):1046-1059. PubMed ID: 28456745
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Are mu-opioid receptor polymorphisms important for clinical opioid therapy?
    Lötsch J; Geisslinger G
    Trends Mol Med; 2005 Feb; 11(2):82-9. PubMed ID: 15694871
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Opioid-related deaths and previous care for drug use and pain relief in Sweden.
    Fugelstad A; Thiblin I; Johansson LA; Ågren G; Sidorchuk A
    Drug Alcohol Depend; 2019 Aug; 201():253-259. PubMed ID: 31260826
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain.
    Gong XD; Wang JY; Liu F; Yuan HH; Zhang WY; Guo YH; Jiang B
    Asian Pac J Cancer Prev; 2013; 14(5):2937-43. PubMed ID: 23803057
    [TBL] [Abstract][Full Text] [Related]  

  • 80. How individual sensitivity to opiates can be predicted by gene analyses.
    Ikeda K; Ide S; Han W; Hayashida M; Uhl GR; Sora I
    Trends Pharmacol Sci; 2005 Jun; 26(6):311-7. PubMed ID: 15925706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.